Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2017 | Correspondence

Comments on “Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial”

Authors: Jose M. Moran, Juan D. Pedrera-Zamorano

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Excerpt

We read with great interest the article reporting on the efficacy and safety of acupuncture and nimodipine therapy for the treatment of mild cognitive impairment after cerebral infarction [1]. We would like to highlight that the article by Wang and colleagues reports outcomes that differ from those initially described [2]. The article reference the pre-specified primary outcomes (efficacy) and only one (Montreal Cognitive Assessment, “MoCA”) of the six pre-specified secondary outcomes. The CONSORT guidelines on the best practice in a trial reporting [3] are implemented to reduce the risk of selective outcome reporting and require that all pre-specified primary and secondary outcomes be reported. …

Wang S, Yang H, Zhang J, Zhang B, Liu T, Gan L, Zheng J. Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complement Altern Med. 2016;16:361.CrossRefPubMedPubMedCentral

Chinese Clinical Trial Registry. 2016. http://www.chictr.org.cn/, Unique Identifier: ChiCTR-IOR-15007366. Accessed 13 Oct 2016.

Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.CrossRefPubMedPubMedCentral

Title: Comments on “Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial”
Authors: Jose M. Moran
Juan D. Pedrera-Zamorano
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-017-1629-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comments on “Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial”

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats

Effects of Mollugo pentaphylla extract on monosodium urate crystal-induced gouty arthritis in mice

Cross-sectional analysis of health-related quality of life and elements of yoga practice

A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee

Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis

Subjective perceived impact of Tai Chi training on physical and mental health among community older adults at risk for ischemic stroke: a qualitative study